KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

UKTI LSO encourages input into the online engagement for the Accelerated Access Review

The UK’s Accelerated Access Review’s online engagement reopens with the launch of the Interim Report (published 27 October 2015).

Online engagement is now open to Industry input via the website until 4 January 2016. Please cascade this email to your industry contacts and also encourage people to sign up for alerts or follow the Review on @AccelAccessto make sure they get all the updates.
Key dates
·         Deadline to submit comments via the Accelerated Access Review website: 4 January 2016
·         Interim report: Published on 27 October 2015
·         Review will conclude: By April 2016
How can people feed in?
In July, a new Accelerated Access Review website was launched to engage online and seek views from industry and other stakeholders on how to improve access to transformative medicines and medical technology in the UK. The first stage of engagement closed on 4 September 2015. Engagement via the Accelerated Access Review website is now re-opened, seeking comments to help refine the propositions outlined in the published Interim Report.
The UK Trade and Investment (UKTI) Life Sciences Organisation (LSO) would like to encourage life sciences industry as well as key partners to contribute to the Accelerated Access Review and provide views (positive and constructive)on the five propositions that have been set out in the interim report.
You can submit your comments until 4 January 2016. Please follow the link below for further information and to contribute your views: http://engage.dh.gov.uk/acceleratedaccess
What is the Accelerated Access Review?
The Accelerated Access Review aims to speed up access to innovative medicines and devices for NHS patients, in particular innovative drugs, devices, digital health and diagnostics for NHS patients. There is a particular focus on how to speed up the use of data and measurement as a catalyst for evidence-based development, commissioning and decommissioning as well as understanding the role digital health will play in the future.
The now published Interim Report sets out 5 propositions:
1)  Putting the patient centre stage: patients should be given a stronger voice at every stage of the innovation pathway
2)  Getting ahead of the curve: a radically new approach is required to accelerate and manage entry into our health system for emerging products which promise the most significant, potentially transformative impact in terms of patient benefit and overall value
3)  Supporting all innovators: the end-to-end innovation pathway can, and should, be more responsive, particularly where this will contribute to better outcomes for patients and more efficient ways of delivering care
4)  Galvanising the NHS: the NHS must be an active partner in promoting innovation and must be incentivised to adopt new products and systems quickly and effectively
5)  Delivering change: building on existing structures the health innovation system needs to be streamlined at both local and national level